Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
The question plaguing the geneticists about the Burns family was: how have they survived? In 2016, several geneticists theorized that certain people may have a good-gene bad-gene scenario taking place…
Continue Reading
A Family Has a Protective Gene That is Keeping Them Alive: Part One
Dr. Rachel Grisham MSK ovarian cancer section head discussed clinical trials investigating PARP inhibitors for ovarian cancer patients. The event was a round table discussion and interview for Targeted Oncology.…
Continue Reading
Studies Show Favorable Results For PARP Inhibitors in the Treatment of Advanced Ovarian Cancer
Tay-Sachs disease has escaped effective treatment since 1883 when an ophthalmologist names Warren Tay found small red spots in the back of the eyes of some infants. According to an…
Continue Reading
Results From the First Clinical Trial for Tay-Sachs Disease Look Promising
Stoke Therapeutics and Acadia Pharmaceuticals made a joint announcement this week through Business Wire of their collaboration in the development of RNA-based medicines to potentially treat rare neurodevelopmental disorders of…
Continue Reading
Stoke Therapeutics and Acadia Pharmaceuticals Collaborate to Develop Medicines for Rare Neurodevelopmental Disorders
source: pixabay.com
CURE® recently conducted an interview with von Hippel-Lindau (VHL) patient Joseph Heisler and his mother, Marirene. Joseph’s father was diagnosed thirty years ago with the genetic (inherited) disease. Shortly thereafter…
Continue Reading
A Discussion of von Hippel-Lindau Disease Thirty Years After Discovery
Photo by Jude Beck on Unsplash
Dr. Douglas Marchuk, professor of genetics at Duke, has spent years studying the genetics of cardiovascular disease. According to a recent article in the Atlantic, his research at the University…
Continue Reading
Their Family Tree Revealed Their Ancestors and a Mysterious Brain Disease
source: pixabay.com
Continued From Part One Case #2 The second case involved a sixteen-year-old male in the ICU unit with suspected bacterial hypoxic respiratory failure associated with viral pneumonia. The teen’s history…
Continue Reading
Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part Two
Source: Pixabay
The International Consortium of FD/MAS invites you to its Film Screening and Community Discussion on the 24th of February at 7:30 pm EST. The event is free and is in…
Continue Reading
Join the FD/MAS 2022 Awareness Celebration
A group of autoimmune diseases called anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is the subject of a preprint under consideration at Pediatric Rheumatology. ANCA-AAV is characterized by damage to small…
Continue Reading
Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One
A year ago, Paddy Doherty’s doctor told him that he had a rare hereditary disease called transthyretin (ATTR) amyloidosis, the same disease that had killed his father. As reported in…
Continue Reading
CRISPR Continues to Cut Impressive Numbers in Beta-Thalassemia, Sickle Cell Disease, and More
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: A Grieving Mother Laments a Lack of Compassion by Nurses When Her Baby Died
Research by three doctors provided a basis for tyrosine kinase inhibitors (TKI) and offered advancements in treatment for renal cell carcinoma (RCC) patients. Two such TKIs, sunitinib and sorafenib, remain…
Continue Reading
Doctors Receive Nobel Prize for Development in Renal Cell Carcinoma Treatment
Positive results were announced today by Anavex Life Sciences, which is based in New York, for its Phase 3 clinical trial of Anavex 2-73. Participants in the trial were female…
Continue Reading
Anavex Announces Significant Results from Phase III Rett Syndrome Trial
Researchers are aware that Black cancer patients experience worse outcomes than white cancer patients due to the differences in access to health care. According to a report in Cancer Network,…
Continue Reading
Studies of Head and Neck Cancer Show That Black Patients Have Worse Overall Survival Than Other People of Color
source: pixabay.com
Recent clinical trials have proven that treatment for relapsed ovarian cancer is not a standard “one size fits all." After a relapse, areas where tumors spread and grow in the…
Continue Reading
Results of Three Clinical Trials Investigating Secondary Surgery For Recurrent Ovarian Cancer
source: pixabay.com
Targeted Oncology recently featured a discussion by Dr. Jennifer Brown, director of Dana Farber’s Chronic Lymphocytic Leukemia Center, on the interim results from the SEQUOIA Phase 3 trial. The trial…
Continue Reading
SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup
Source: Pixabay.com
It is common practice to treat multiple myeloma patients with a stem cell transplant. In the GENESIS trial, the stem cells were autologous (from the patient’s own peripheral blood or bone…
Continue Reading
GENESIS Trial: Motixafortide And G-SCF Prepared Multiple Myeloma Patients for Transplant
For the last seven years, the Global Genes Rare Compassion Program has been providing medical students with an opportunity to bond with patients and families who have been diagnosed with…
Continue Reading
A Unique Organization Dedicated to Rare Diseases
source: pixabay.com
U.S. News carried an article reporting that in a recent study, researchers have identified minute amounts of cancer (organoids) in fallopian tube tissue. The significance of the discovery is that…
Continue Reading
New Study May Provide Lifesaving Detection For Women With Ovarian Cancer
Professor Miranda Orr of Winston Salem’s School of Medicine in North Carolina leads a team of investigators who have detected senescent cells in patients with Alzheimer’s disease. These cells, found…
Continue Reading
A Potential New Target for Alzheimer’s Called Zombie Cells
The World Health Organization (the WHO) announced World Leprosy Day which this year will be celebrated on January 30th. The theme of the celebration is “United for Dignity.” It…
Continue Reading
January 30th is World Leprosy Day: Let Us Be United for Dignity
Julia Lefelar, a resident of Gaithersburg, MD, was telling a friend about her years of seeing different doctors trying to find the cause of her illness. After a while, her…
Continue Reading
After Being Examined By Doctors for 17 Years, Julia Finally Received an Accurate MOG Diagnosis
source: pixabay.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…
Continue Reading
Compassion Corner: A Patient Almost Died Because of a Doctor’s Lack of Understanding and Compassion
The Critical Path Institute (C-Path), formed in 2005, is a nonprofit, independent (public/private) partnership. The Institute evolved from the FDA’s 2004 White Paper known as the Critical Path Report and…
Continue Reading
The Critical Path Institute and the FDA
Early detection is the key to treating so many types of cancer. Autoimmune hepatitis (AIH), chronic inflammation of the liver, is brought about by an immune system disorder. AIH must…
Continue Reading
New Antibody Test for Autoimmune Hepatitis